top of page

Important Disclaimers
This article (the “Article”) is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to purchase any investment or any securities. This Article does not constitute investment advice and is not intended to be relied upon as the basis for an investment decision, and is not, and should not be assumed to be, complete. Readers should make their own investigations and evaluations of the information contained herein. The information contained herein does not take into account the particular investment objectives or financial circumstances of any specific person or entity who may receive it. Each reader should consult its own attorney, business adviser and tax adviser as to legal, business, tax and related matters concerning the information contained herein.  Except where otherwise indicated herein, the information provided herein is based on matters as they exist as of the date of preparation and not as of any future date and will not be updated or otherwise revised to reflect information that subsequently becomes available, or circumstances existing or changes occurring after the date of preparation. Certain information contained in this Article constitutes “forward-looking statements,” which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,”  “target,” “project,” “estimate,” “intend,” “continue” or “believe,” or the negatives thereof or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results may differ materially from those reflected or contemplated in such forward-looking statements. Readers should not rely on these forward-looking statements.  Certain information reflects subjective determinations which may prove to be incorrect. There can be no assurance that the estimates or projections will be accurate or that historical trends will continue. In considering the prior performance information contained herein, readers should bear in mind past performance is not necessarily indicative of future results. All rights reserved. The material may not be reproduced or distributed, in whole or in part, without the prior written permission of PrimeAlpha LLC.

The Value of Never Giving Up with Jonas Martenson at Ress Capital

Jonas Martenson is the founder of Ress Capital, an alternative investment manager focusing on US life insurance policies. Their fund, Ress Life Investments celebrates its 10th anniversary in 2021.


“Straight off from university in Sweden, I went to Switzerland and worked for Electronics Options Exchanges. I knew I wanted to do something different and it took me some time to find that, I never gave up.


During the 2008 financial crisis, the life settlement investment market shrank in size. So I saw this as an opportunity to launch a life settlement fund that offers risk diversification and attractive returns. We listened to what investors were asking for, so we did something different and provided a liquid product versus the traditional closed-ended long hold funds.


Our policies work by buying premium US life insurances policies and wait until a policy pays out, which then gets an increased net asset value. We deliver to investors stable returns that is not linked to the general economy. I think my superpower is being stubborn and never wanting to give up, which is probably true for many other entrepreneurs as well. And of course, you have to be good at understanding and listening to people.”


Ress Capital Logo

Jonas Martenson, Founder


Resscapital AB is an alternative investment fund manager (AIFM) authorized and regulated by the Swedish Financial Services Authority (Finansinspektionen). They have since 2011 bought a diversified life insurance portfolio on behalf of Ress Life Investments, which is listed at NASDAQ Copenhagen. Proprietary portfolio management systems and pricing models have been developed, in order to gain an advantage when purchasing policies. The company also collaborates with external medical underwriters specializing in senior mortality in order to provide more accurate assessments and mortality distributions. Their management team has extensive experience in life settlements, complementary backgrounds, and international experience from having worked at major banks and hedge funds. The board of directors consists of both successful entrepreneurs and senior managers with extensive experience in the financial industry.



Welcome to PrimeAlpha's interview series where we will share insights from industry practitioners discussing their journey and their discoveries.


Check us out on these platforms

Spotify Podcast Link
iHeart Radio Podcast Link
Amazon Podcast Link
YouTube Podcast Link
Apple Podcast Link






Commentaires


Access PrimeAlpha Alternatives Education, Research, and Database of Managers and Investors
bottom of page